Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q3 2016 · 10-Q
Revenue—
Net Income-$2.87M-$2.87MN/M vs Q3 2015 EPS Diluted-$0.13-$0.13N/M vs Q3 2015 Operating Income-$3,717,575N/M Operating Cash Flowderived-$3,121,376N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 4, 2016 · 35 d after period end